Monthly News Roundup - May 2024
FDA Clears GSK’s Benlysta Autoinjector for Systemic Lupus Erythematosus (SLE) in Children
In May, the U.S Food and Drug Administration (FDA) cleared GSK’s Benlysta subcutaneous autoinjector (given as an injection under the skin) to be...
Read more »